For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts
Oneindia App Download

Dr Reddy seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V

|
Google Oneindia News

New Delhi, Oct 2: The Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.

Dr Reddys seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V

The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distribution. Upon regulatory approval in India, RDIF will supply to drugmaker Dr Reddy's 100 million doses of the vaccine, the firm said last month.

"The Dr Reddy's Laboratories has applied to the DCGI seeking permission to conduct phase-3 human clinical trials of the Sputnik V vaccine against COVID-19 developed by Russia. The DCGI will carry out a technical evaluation of the application before giving its approval," a source told PTI.

Shocking: Nearly 500,000 sharks may face slaughter for preparation of coronavirus vaccineShocking: Nearly 500,000 sharks may face slaughter for preparation of coronavirus vaccine

Sources said it would be multi-centre, observer-blind, randomised controlled study. The phase-3 trial of Sputnik V is underway in Russia since September 1 on around 40,000 subjects, they added.

Recommended Video

Yogi Adityanath warns: Rapists will be destroyed | Oneindia News

Sputnik V has been developed by Gamaleya National Research Centre of Epidemiology and Microbiology and RDIF. Currently, two vaccine candidates, the indigenously developed by Bharat Biotech in collaboration with ICMR and the one developed by Zydus Cadila Ltd, are in phase 2 of human clinical trials.

The Pune-based Serum Institute of India, which has partnered with AstraZeneca for manufacturing the Oxford COVID-19 vaccine candidate, is also conducting phase 2 and 3 human clinical trials in India.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X